Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Chang VK, Imperial MZ, Phillips PPJ, Velásquez GE, Nahid P, Vernon A, Kurbatova EV, Swindells S, Chaisson RE, Dorman SE, Johnson JL, Weiner M, Sizemore EE, Whitworth W, Carr W, Bryant KE, Burton D, Dooley KE, Engle M, Nsubuga P, Diacon AH, Nhung NV, Dawson R, Savic RM; AIDS Clinical Trial Group; Tuberculosis Trials Consortium.
Chang VK, et al. Among authors: carr w.
Nat Commun. 2024 Oct 30;15(1):9400. doi: 10.1038/s41467-024-53273-7.
Nat Commun. 2024.
PMID: 39477924
Free PMC article.
Clinical Trial.